The ratio of nicotinic acid to nicotinamide as a microbial biomarker for assessing cell therapy product sterility

Controlling microbial risks in cell therapy products (CTPs) is important for product safety. Here, we identified the nicotinic acid (NA) to nicotinamide (NAM) ratio as a biomarker that detects a broad spectrum of microbial contaminants in cell cultures. We separately added six different bacterial sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Jiayi, Cui, Liang, Natarajan, Meenubharathi, Barone, Paul W., Wolfrum, Jacqueline M., Lee, Yie Hou, Rice, Scott A., Springs, Stacy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065052/
https://www.ncbi.nlm.nih.gov/pubmed/35573051
http://dx.doi.org/10.1016/j.omtm.2022.04.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065052/
https://www.ncbi.nlm.nih.gov/pubmed/35573051
http://dx.doi.org/10.1016/j.omtm.2022.04.006

Ejemplares similares